Command Palette

Search for a command to run...

NATCOPHARM
839.8(-0.71%)
1W: +6.32%

Natco Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Latest quarter shows revenue increase from ₹1,031.40 Crore to ₹1,371.10 Crore, indicating strong sales recovery.
  • Net profit rose to ₹676.50 Crore, reflecting improved cost management and operational efficiency.
  • Operating profit margin improved significantly, reaching 55.02%, suggesting better control over expenses.
NEGATIVES
  • Revenue decreased from ₹1,362.60 Crore in the previous quarter, highlighting potential demand fluctuations.
  • Net profit fell to ₹132.40 Crore by the end of the year, raising concerns about sustainability.
  • High expenses of ₹818.20 Crore in the latest quarter could pressure future profitability.

Quarterly Results Data (Numbers are in Crore)

FieldTrendJun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Jun 25
Revenue
1,140.501,031.40758.601,068.301,362.601,371.10474.801,328.90
Expenses
660.20621.20539.30632.70607.10616.70487.40818.70
Operating Profit
480.30410.20219.30435.60755.50754.40-12.60510.20
Other Income
19.7029.40374248.1063.80176.3061.70
Interest
4.204.204.606.205.204.104.403.20
Depreciation
43.5043.6044.2055.5044.1045.804757.60
Profit Before Tax
500439.60256.30477.60803.60818.20163.70571.90
Tax
79.7070.6043.6091.30135.10141.7031.3091.60
Net Profit
420.30369212.70386.30668.50676.50132.40480.30
Eps in Rs
23.2620.6011.8821.5637.3237.817.4326.84

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.